http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-0316081-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B55-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-54
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
filingDate 2003-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c358bbde8d4d2c71e3bbd62dc0d5cd1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2adbd2a30ad5449f8f17e9316ada0f3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d4549f24c5461436de38c32b10d93e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9de19bda717167d37bb4aa1e69d4cbae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_764218601003c010c06e4a348f62e37f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe360beb147e180cee749c6b6c3a7f93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56f3516f77437082d63866db8984e165
publicationDate 2005-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-0316081-A
titleOfInvention 2-Pyridone Derivatives as Neutrophil Elastase Inhibitors
abstract "2-PYRIDONE DERIVATIVES AS NEUTROPHYLE ELASTASE INHIBITORS". The present invention provides novel compounds of formula (I): wherein R¬1¬, R¬4¬, R¬5¬, G¬1¬, G¬2¬, X, L, Y¬1¬, Y¬ 2¬, en are as defined in the specification and also the optical isomers, racemates and tautomers thereof, as well as the pharmaceutically acceptable salts thereof. The invention also provides processes for preparation, compositions containing said compounds and their use in therapy procedures. The compounds of the invention are neutrophil elastase inhibitors.
priorityDate 2002-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425154543
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8871

Total number of triples: 64.